Maso Capital Partners’s Takeda Pharmaceutical TAK Stock Holding History

Maso Capital Partners’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-91,367	Closed	-$1.66M	–	58
2020 Q4	$1.66M	Sell	91,367 -84,432	-48%	-$1.48M	0.45%	31
2020 Q3	$3.14M	Sell	175,799 -40,967	-19%	-$746K	1.75%	10
2020 Q2	$3.89M	Hold	216,766	–	–	1.57%	9
2020 Q1	$3.29M	Buy	216,766 +35,141	+19%	+$637K	0.85%	12
2019 Q4	$3.58M	Buy	181,625 +53,854	+42%	+$1.03M	1.15%	13
2019 Q3	$2.2M	Hold	127,771	–	–	0.79%	15
2019 Q2	$2.26M	Sell	127,771 -1,600	-1%	-$29.1K	1.19%	14
2019 Q1	$2.63M	Buy	+129,371	New	+$2.6M	1.81%	14

Other funds holding TAK

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Maso Capital Partners's TAK Position: Q1 2021 in Review

Maso Capital Partners sold out of Takeda Pharmaceutical (TAK) in Q1 2021, closing a stake of 91,367 shares — an estimated $1.66M sold.

Maso Capital Partners first reported a position in TAK in Q1 2019 and held it in 8 quarters. The position peaked at $3.89M in Q2 2020. 316 funds tracked by Wall St. Rank hold TAK as of Q1 2021.

Maso Capital Partners reported no remaining Takeda Pharmaceutical position as of Q1 2021 after selling out during the quarter.
Maso Capital Partners sold 91,367 Takeda Pharmaceutical shares in Q1 2021, an estimated $1.66M.
Maso Capital Partners first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 8 quarters.
Maso Capital Partners's Takeda Pharmaceutical position peaked at $3.89M in Q2 2020.
316 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2021.

Based on Maso Capital Partners's 13F filing for Q1 2021, filed 17 May 2021.